GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 79 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $296,000 | +10.0% | 24,201 | +6.1% | 0.00% | – |
Q3 2016 | $269,000 | +49.4% | 22,820 | +10.2% | 0.00% | – |
Q2 2016 | $180,000 | +69.8% | 20,714 | +3.1% | 0.00% | – |
Q1 2016 | $106,000 | -28.4% | 20,099 | +5.4% | 0.00% | – |
Q4 2015 | $148,000 | -34.5% | 19,066 | -33.7% | 0.00% | – |
Q3 2015 | $226,000 | -11.4% | 28,754 | +2.0% | 0.00% | – |
Q2 2015 | $255,000 | -28.2% | 28,190 | +3.0% | 0.00% | – |
Q1 2015 | $355,000 | +12.0% | 27,361 | +17.5% | 0.00% | – |
Q4 2014 | $317,000 | +40.3% | 23,278 | -7.7% | 0.00% | – |
Q3 2014 | $226,000 | -34.7% | 25,227 | -1.3% | 0.00% | – |
Q2 2014 | $346,000 | +31.1% | 25,559 | -3.9% | 0.00% | – |
Q1 2014 | $264,000 | -18.3% | 26,593 | +9.4% | 0.00% | – |
Q4 2013 | $323,000 | +18.3% | 24,304 | +8.2% | 0.00% | – |
Q3 2013 | $273,000 | -95.8% | 22,456 | -96.4% | 0.00% | -100.0% |
Q2 2013 | $6,462,000 | – | 624,510 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 500,000 | $6,765,000 | 5.83% |
Gruss & Co., LLC | 200,000 | $2,706,000 | 3.07% |
First Light Asset Management, LLC | 150,076 | $2,031,000 | 1.37% |
Curi RMB Capital, LLC | 1,032,369 | $13,968,000 | 0.88% |
Camber Capital Management LP | 908,100 | $12,287,000 | 0.80% |
CADIAN CAPITAL MANAGEMENT, LP | 887,500 | $12,008,000 | 0.36% |
PARNASSUS INVESTMENTS, LLC | 2,118,127 | $28,658,000 | 0.25% |
Visium Asset Management, LP | 786,468 | $10,641,000 | 0.16% |
PUTNAM INVESTMENTS LLC | 5,198,367 | $70,333,000 | 0.15% |
Capital Impact Advisors, LLC | 13,933 | $189,000 | 0.14% |